0001567619-22-001334.txt : 20220119
0001567619-22-001334.hdr.sgml : 20220119
20220119183431
ACCESSION NUMBER: 0001567619-22-001334
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220114
FILED AS OF DATE: 20220119
DATE AS OF CHANGE: 20220119
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LAWLIS V BRYAN
CENTRAL INDEX KEY: 0001247681
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26727
FILM NUMBER: 22540047
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC
CENTRAL INDEX KEY: 0001048477
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 680397820
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
BUSINESS PHONE: 4155066700
MAIL ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
4
1
doc1.xml
FORM 4
X0306
4
2022-01-14
0
0001048477
BIOMARIN PHARMACEUTICAL INC
BMRN
0001247681
LAWLIS V BRYAN
C/O BIOMARIN PHARMACEUTICAL INC.
105 DIGITAL DRIVE
NOVATO
CA
94949
1
0
0
0
Common Stock
2022-01-14
4
M
0
4250
37.46
A
28220
D
Common Stock
2022-01-14
4
S
0
4250
87.61
D
23970
D
Stock Option (Right to buy Common Stock)
37.46
2022-01-14
4
M
0
4250
0
D
2012-11-08
2022-05-07
Common Stock
4250
4250
D
Trade made pursuant to a 10b5-1 plan executed on July 29, 2021.
Reflects the number of options outstanding after the transactions from this specific stock option grant.
/s/ Eric Fleekop, Attorney-in-Fact
2022-01-19